ALAS1 and autoimmune pancreatitis: Heme not only downregulates ALAS1 transcription through negative feedback but also reduces hepatic ALAS1 levels by interfering with mRNA stability or blocking mature enzymes from entering the mitochondria.[19] However, this drug is expensive, and its availability is limited in China due to the difficulty in diagnosing AIP.